1/15
11:24 am
wgs
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
1/14
10:39 am
wgs
GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum [Seeking Alpha]
Low
Report
GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum [Seeking Alpha]
1/12
08:05 am
wgs
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance [Yahoo! Finance]
Medium
Report
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance [Yahoo! Finance]
1/12
07:30 am
wgs
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
High
Report
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
1/8
08:30 am
wgs
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
Low
Report
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
1/7
08:30 am
wgs
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
Low
Report
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
1/6
07:48 pm
wgs
A Look At GeneDx Holdings (WGS) Valuation After New CMO Appointment And Record Rare Disease Genomics Year [Yahoo! Finance]
Low
Report
A Look At GeneDx Holdings (WGS) Valuation After New CMO Appointment And Record Rare Disease Genomics Year [Yahoo! Finance]
1/6
08:30 am
wgs
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
Medium
Report
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
1/5
08:30 am
wgs
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
Medium
Report
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
1/1
07:31 am
wgs
What Do Analysts Think About GeneDx Holdings Corp. (WGS)? [Yahoo! Finance]
Low
Report
What Do Analysts Think About GeneDx Holdings Corp. (WGS)? [Yahoo! Finance]
12/30
08:00 am
wgs
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
Low
Report
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
12/22
08:16 am
wgs
GeneDx (NASDAQ:WGS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $160.00 to $170.00. They now have a "buy" rating on the stock.
Low
Report
GeneDx (NASDAQ:WGS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $160.00 to $170.00. They now have a "buy" rating on the stock.
12/15
08:43 am
wgs
GeneDx (NASDAQ:WGS) was given a new $155.00 price target on by analysts at Wells Fargo & Company.
Low
Report
GeneDx (NASDAQ:WGS) was given a new $155.00 price target on by analysts at Wells Fargo & Company.
12/15
08:30 am
wgs
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
Low
Report
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
12/14
07:30 am
wgs
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Could Be 40% Below Their Intrinsic Value Estimate [Yahoo! Finance]
Medium
Report
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Could Be 40% Below Their Intrinsic Value Estimate [Yahoo! Finance]
12/12
08:06 am
wgs
GeneDx (NASDAQ:WGS) had its price target raised by analysts at BTIG Research from $165.00 to $200.00. They now have a "buy" rating on the stock.
Medium
Report
GeneDx (NASDAQ:WGS) had its price target raised by analysts at BTIG Research from $165.00 to $200.00. They now have a "buy" rating on the stock.
11/30
03:20 pm
wgs
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Low
Report
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
11/6
08:00 am
wgs
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
Low
Report
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
11/4
11:33 am
wgs
Artificial Intelligence Powered Rare Disease Diagnosis Research Report 2025: Market to Surpass $5.5 Billion by 2029 on Accelerated Adoption of Predictive and Personalized Healthcare - Forecast to 2034 [Yahoo! Finance]
Low
Report
Artificial Intelligence Powered Rare Disease Diagnosis Research Report 2025: Market to Surpass $5.5 Billion by 2029 on Accelerated Adoption of Predictive and Personalized Healthcare - Forecast to 2034 [Yahoo! Finance]
11/4
11:05 am
wgs
GeneDx (NASDAQ:WGS) had its price target raised by analysts at Wells Fargo & Company from $95.00 to $140.00. They now have an "equal weight" rating on the stock.
Low
Report
GeneDx (NASDAQ:WGS) had its price target raised by analysts at Wells Fargo & Company from $95.00 to $140.00. They now have an "equal weight" rating on the stock.
11/4
08:00 am
wgs
GeneDx to Participate in Upcoming Investor Conferences
Medium
Report
GeneDx to Participate in Upcoming Investor Conferences
11/1
01:05 am
wgs
Low
Report
10/29
10:08 am
wgs
GeneDx (NASDAQ:WGS) was given a new $160.00 price target on by analysts at Canaccord Genuity Group Inc..
Medium
Report
GeneDx (NASDAQ:WGS) was given a new $160.00 price target on by analysts at Canaccord Genuity Group Inc..
10/29
08:08 am
wgs
GeneDx (NASDAQ:WGS) had its price target raised by analysts at BTIG Research from $140.00 to $165.00. They now have a "buy" rating on the stock.
Medium
Report
GeneDx (NASDAQ:WGS) had its price target raised by analysts at BTIG Research from $140.00 to $165.00. They now have a "buy" rating on the stock.
10/29
07:19 am
wgs
GeneDx (NASDAQ:WGS) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
GeneDx (NASDAQ:WGS) had its "buy" rating reaffirmed by analysts at Guggenheim.